期刊
TISSUE ENGINEERING PART B-REVIEWS
卷 20, 期 5, 页码 455-467出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/ten.teb.2013.0462
关键词
-
类别
资金
- Beta Cell Biology Consortium
- National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK089561]
Type 1 diabetes mellitus is an autoimmune disease resulting from the destruction of insulin-producing pancreatic beta-cells. Cell-based therapies, involving the transplantation of functional beta-cells into diabetic patients, have been explored as a potential long-term treatment for this condition; however, success is limited. A tissue engineering approach of culturing insulin-producing cells with extracellular matrix (ECM) molecules in three-dimensional (3D) constructs has the potential to enhance the efficacy of cell-based therapies for diabetes. When cultured in 3D environments, insulin-producing cells are often more viable and secrete more insulin than those in two dimensions. The addition of ECM molecules to the culture environments, depending on the specific type of molecule, can further enhance the viability and insulin secretion. This review addresses the different cell sources that can be utilized as beta-cell replacements, the essential ECM molecules for the survival of these cells, and the 3D culture techniques that have been used to benefit cell function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据